These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 16415793)

  • 1. Local recurrence of myxofibrosarcoma is associated with increase in tumour grade and cytogenetic aberrations, suggesting a multistep tumour progression model.
    Willems SM; Debiec-Rychter M; Szuhai K; Hogendoorn PC; Sciot R
    Mod Pathol; 2006 Mar; 19(3):407-16. PubMed ID: 16415793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myxofibrosarcoma. Clinicopathologic analysis of 75 cases with emphasis on the low-grade variant.
    Mentzel T; Calonje E; Wadden C; Camplejohn RS; Beham A; Smith MA; Fletcher CD
    Am J Surg Pathol; 1996 Apr; 20(4):391-405. PubMed ID: 8604805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging mass spectrometry of myxoid sarcomas identifies proteins and lipids specific to tumour type and grade, and reveals biochemical intratumour heterogeneity.
    Willems SM; van Remoortere A; van Zeijl R; Deelder AM; McDonnell LA; Hogendoorn PC
    J Pathol; 2010 Dec; 222(4):400-9. PubMed ID: 20839361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between tumour progression and vascularity in myxofibrosarcoma and myxoid/round cell liposarcoma.
    Mentzel T; Brown LF; Dvorak HF; Kuhnen C; Stiller KJ; Katenkamp D; Fletcher CD
    Virchows Arch; 2001 Jan; 438(1):13-22. PubMed ID: 11213831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal evaluation of cytogenetic aberrations in prostatic cancer: tumours that recur in time display an intermediate genetic status between non-persistent and metastatic tumours.
    Alers JC; Krijtenburg PJ; Hop WC; Bolle WA; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H
    J Pathol; 1998 Jul; 185(3):273-83. PubMed ID: 9771481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytogenetic analysis of 46 pleomorphic soft tissue sarcomas and correlation with morphologic and clinical features: a report of the CHAMP Study Group. Chromosomes and MorPhology.
    Mertens F; Fletcher CD; Dal Cin P; De Wever I; Mandahl N; Mitelman F; Rosai J; Rydholm A; Sciot R; Tallini G; Van den Berghe H; Vanni R; Willén H
    Genes Chromosomes Cancer; 1998 May; 22(1):16-25. PubMed ID: 9591630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myxofibrosarcoma. A study of 30 cases.
    Angervall L; Kindblom LG; Merck C
    Acta Pathol Microbiol Scand A; 1977 Mar; 85A(2):127-40. PubMed ID: 15396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular/intramuscular myxoma and grade I myxofibrosarcoma are characterized by distinct genetic alterations and specific composition of their extracellular matrix.
    Willems SM; Mohseny AB; Balog C; Sewrajsing R; Briaire-de Bruijn IH; Knijnenburg J; Cleton-Jansen AM; Sciot R; Fletcher CD; Deelder AM; Szuhai K; Hensbergen PJ; Hogendoorn PC
    J Cell Mol Med; 2009 Jul; 13(7):1291-301. PubMed ID: 19320777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-grade myxofibrosarcoma: a clinicopathologic analysis of 49 cases treated at a single institution with simultaneous assessment of the efficacy of 3-tier and 4-tier grading systems.
    Huang HY; Lal P; Qin J; Brennan MF; Antonescu CR
    Hum Pathol; 2004 May; 35(5):612-21. PubMed ID: 15138937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of an association between 6q13-21 chromosome aberrations and locally aggressive behavior in patients with cartilage tumors.
    Sawyer JR; Swanson CM; Lukacs JL; Nicholas RW; North PE; Thomas JR
    Cancer; 1998 Feb; 82(3):474-83. PubMed ID: 9452264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytogenetic characterization of peripheral nerve sheath tumours: a report of the CHAMP study group.
    Mertens F; Dal Cin P; De Wever I; Fletcher CD; Mandahl N; Mitelman F; Rosai J; Rydholm A; Sciot R; Tallini G; van Den Berghe H; Vanni R; Willén H
    J Pathol; 2000 Jan; 190(1):31-8. PubMed ID: 10640989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytogenetic and spectral karyotype analyses of benign and malignant cartilage tumours.
    Sjögren H; Orndal C; Tingby O; Meis-Kindblom JM; Kindblom LG; Stenman G
    Int J Oncol; 2004 Jun; 24(6):1385-91. PubMed ID: 15138578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytogenetic analysis of myxoid liposarcoma and myxofibrosarcoma by array-based comparative genomic hybridisation.
    Ohguri T; Hisaoka M; Kawauchi S; Sasaki K; Aoki T; Kanemitsu S; Matsuyama A; Korogi Y; Hashimoto H
    J Clin Pathol; 2006 Sep; 59(9):978-83. PubMed ID: 16751306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1.
    Fang Y; Elahi A; Denley RC; Rao PH; Brennan MF; Jhanwar SC
    Anticancer Res; 2009 Apr; 29(4):1255-62. PubMed ID: 19414372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myxofibrosarcoma in adolescents and young adults: a clinicopathologic study of 17 cases.
    Arispe Angulo KR; Logan S; Bahrami A; John I; Billings SD; Agrawal S; Bena J; Mesko N; Folpe AL; Fritchie KJ
    Hum Pathol; 2023 Dec; 142():90-95. PubMed ID: 37742946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minichromosome maintenance protein in myxofibrosarcoma.
    Sington JD; Freeman A; Morris LS; Vowler SL; Arch BN; Fisher C; Coleman N
    Mod Pathol; 2004 Feb; 17(2):235-40. PubMed ID: 14685255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary sinonasal myxofibrosarcoma: a clinicopathological study of five cases and review of the literature.
    Dermawan JK; Whaley RD; Gjeorgjievski SG; Habeeb O; Billings SD
    Pathology; 2022 Feb; 54(1):63-70. PubMed ID: 34303554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Low malignancy myxofibrosarcoma versus low malignancy fibromyxoid sarcoma. Distinct entities with similar names but different clinical course].
    Mentzel T; Katenkamp D; Fletcher CD
    Pathologe; 1996 Mar; 17(2):116-21. PubMed ID: 8650138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hidden chromosome abnormalities in haematological malignancies detected by multicolour spectral karyotyping.
    Veldman T; Vignon C; Schröck E; Rowley JD; Ried T
    Nat Genet; 1997 Apr; 15(4):406-10. PubMed ID: 9090389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent chromosomal imbalances and structurally abnormal breakpoints within complex karyotypes of malignant peripheral nerve sheath tumour and malignant triton tumour: a cytogenetic and molecular cytogenetic study.
    Bridge RS; Bridge JA; Neff JR; Naumann S; Althof P; Bruch LA
    J Clin Pathol; 2004 Nov; 57(11):1172-8. PubMed ID: 15509679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.